|
Originally published In Press as doi:10.1074/jbc.M303988200 on June 9, 2003
J. Biol. Chem., Vol. 278, Issue 34, 32367-32372, August 22, 2003
RSK2 Activity Is Regulated by Its Interaction with PEA-15*
Hema Vaidyanathan and
Joe W. Ramos
From the
Department of Cell Biology and Neuroscience, Rutgers, The State
University of New Jersey, Piscataway, New Jersey 08854
The ERK MAP (mitogen-activated protein) kinase cascade modulates many
cellular processes including transcription, adhesion, growth, survival, and
proliferation. One target substrate of ERK involved in regulating
transcription is the p90 ribosomal S6 kinase (RSK) isozyme, RSK2. Here we
demonstrate that a small death effector domain-containing protein called
PEA-15 binds RSK2. RSK2 and PEA-15 (phosphoprotein
enriched in astrocytes, 15 kDa) co-precipitated from
cells and were colocalized in the cytoplasm. Furthermore, purified PEA-15
bound in vitro translated RSK2, suggesting that these proteins
interact directly. PEA-15 does not bind to RSK1 and therefore exhibits some
binding specificity. RSK2 binds the COOH terminus of PEA-15 and does not
interact with its NH2-terminal death effector domain. We show that
this interaction has functional consequences including the inhibition of
RSK2-dependent CREB transcription. PEA-15 expression also blocks histone H3
phosphorylation, an RSK2-dependent event that may contribute to effects on
gene expression. These results can be attributed to two effects of PEA-15 on
RSK2. First, PEA-15 blocks nuclear accumulation of RSK2 after epidermal growth
factor stimulation. Second, PEA-15 inhibits RSK2 kinase activity by 50%. A
mutant of PEA-15 that binds RSK2 but is localized to the nucleus had no effect
on RSK2-dependent transcription. Interestingly, this mutant also did not
affect RSK2 kinase activity. This may indicate that cytoplasmic retention of
RSK2 is also required for PEA-15 to impair kinase activity. PEA-15 does not
alter ERK phosphorylation of RSK2 and is not itself a substrate of RSK2. Hence
the effects of PEA-15 on RSK2 represent a novel mechanism for the regulation
of RSK2-mediated signaling.
Received for publication, April 16, 2003
, and in revised form, June 9, 2003.
* This work was supported by grants from the National Institutes of Health
(CA93849-01), the American Cancer Society (TBE-103363), and the Johnson and
Johnson Foundation. The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be hereby
marked "advertisement" in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Nelson Biological Laboratories,
Rutgers, The State University of New Jersey, 604 Allison Rd., Piscataway, NJ
08854. Tel.: 732-445-8084; Fax: 732-445-5870; E-mail:
ramos{at}biology.rutgers.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Finlay and K. Vuori
Novel Noncatalytic Role for Caspase-8 in Promoting Src-Mediated Adhesion and Erk Signaling in Neuroblastoma Cells
Cancer Res.,
December 15, 2007;
67(24):
11704 - 11711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Vaidyanathan, J. Opoku-Ansah, S. Pastorino, H. Renganathan, M. L. Matter, and J. W. Ramos
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15
PNAS,
December 11, 2007;
104(50):
19837 - 19842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Perfetti, F. Oriente, S. Iovino, A. T. Alberobello, A. P. M. Barbagallo, I. Esposito, F. Fiory, R. Teperino, P. Ungaro, C. Miele, et al.
Phorbol Esters Induce Intracellular Accumulation of the Anti-apoptotic Protein PED/PEA-15 by Preventing Ubiquitinylation and Proteasomal Degradation
J. Biol. Chem.,
March 23, 2007;
282(12):
8648 - 8657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Miele, G. A. Raciti, A. Cassese, C. Romano, F. Giacco, F. Oriente, F. Paturzo, F. Andreozzi, A. Zabatta, G. Troncone, et al.
PED/PEA-15 Regulates Glucose-Induced Insulin Secretion by Restraining Potassium Channel Expression in Pancreatic {beta}-Cells
Diabetes,
March 1, 2007;
56(3):
622 - 633.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Glading, J. A. Koziol, J. Krueger, and M. H. Ginsberg
PEA-15 Inhibits Tumor Cell Invasion by Binding to Extracellular Signal-Regulated Kinase 1/2
Cancer Res.,
February 15, 2007;
67(4):
1536 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Chaturvedi, H. M. Poppleton, T. Stringfield, A. Barbier, and T. B. Patel
Subcellular Localization and Biological Actions of Activated RSK1 Are Determined by Its Interactions with Subunits of Cyclic AMP-Dependent Protein Kinase
Mol. Cell. Biol.,
June 15, 2006;
26(12):
4586 - 4600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Krueger, F.-L. Chou, A. Glading, E. Schaefer, and M. H. Ginsberg
Phosphorylation of Phosphoprotein Enriched in Astrocytes (PEA-15) Regulates Extracellular Signal-regulated Kinase-dependent Transcription and Cell Proliferation
Mol. Biol. Cell,
August 1, 2005;
16(8):
3552 - 3561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Silverman, M. Frodin, S. Gammeltoft, and J. L. Maller
Activation of p90Rsk1 Is Sufficient for Differentiation of PC12 Cells
Mol. Cell. Biol.,
December 15, 2004;
24(24):
10573 - 10583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. P. Roux and J. Blenis
ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions
Microbiol. Mol. Biol. Rev.,
June 1, 2004;
68(2):
320 - 344.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|